UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antiviral therapies and prospects for a cure of chronic hepatitis B

Cold Spring Harbor perspectives in medicine, 2015-04, Vol.5 (4), p.a021501-a021501

2015

Volltextzugriff (PDF)

Hepatitis B virus induced hepatocellular carcinoma

Cancer letters, 2009-12, Vol.286 (1), p.52-59

2009

Volltextzugriff (PDF)

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection

Antiviral research, 2004-10, Vol.64 (1), p.1-15

Zoulim, Fabien

2004

Volltextzugriff (PDF)

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

Alimentary pharmacology & therapeutics, 2017-12, Vol.46 (11-12), p.1054-1060

2017

Volltextzugriff (PDF)

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells

Journal of general virology, 2009-01, Vol.90 (1), p.127-135

2009

Volltextzugriff (PDF)

New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus

Journal of hepatology, 2016-04, Vol.64 (1), p.S117-S131

2016

Volltextzugriff (PDF)

New approaches to the management of hepatitis C in haemophilia in 2012

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (s4), p.28-33

2012

Volltextzugriff (PDF)

Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score

Journal of viral hepatitis, 2014-09, Vol.21 (9), p.e98-e107

2014

Volltextzugriff (PDF)

Mutations affecting the replication capacity of the hepatitis B virus

Journal of viral hepatitis, 2006-07, Vol.13 (7), p.427-434

2006

Volltextzugriff (PDF)

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus

Oncogene, 2017-11, Vol.36 (48), p.6712-6724

2017

Volltextzugriff (PDF)

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.897-904

2016

Volltextzugriff (PDF)

Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion

Clinical infectious diseases, 2007-09, Vol.45 (5), p.624-632

2007

Volltextzugriff (PDF)

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia

Clinical microbiology and infection, 2018-11, Vol.24 (11), p.1215.e1-1215.e4

2018

Volltextzugriff (PDF)

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.125-131

2011

Volltextzugriff (PDF)

Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients

Journal of viral hepatitis, 2011-01, Vol.18 (1), p.61-69

2011

Volltextzugriff (PDF)

Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co‐infected patients from Western Africa

Journal of viral hepatitis, 2018-10, Vol.25 (10), p.1121-1131

2018

Volltextzugriff (PDF)

Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis

Journal of viral hepatitis, 2010-12, Vol.17 (12), p.887-895

2010

Volltextzugriff (PDF)

Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemia

Journal of hepatology, 2017, Vol.66 (1), p.S528-S529

2017

Volltextzugriff (PDF)

Implications of Unc5A depletion for hepatocyte survival in chronic liver diseases upon induction of the unfolded protein response

Journal of hepatology, 2017, Vol.66 (1), p.S647-S647

2017

Volltextzugriff (PDF)

International coalition to eliminate hepatitis B - progress report

Journal of hepatology, 2017, Vol.66 (1), p.S698-S698

2017

Volltextzugriff (PDF)

New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India

Journal of viral hepatitis, 2013-03, Vol.20 (3), p.209-218

2013

Volltextzugriff (PDF)

Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy

Journal of viral hepatitis, 2016-05, Vol.23 (5), p.387-398

2016

Volltextzugriff (PDF)

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

Nephrology, dialysis, transplantation, 2009-03, Vol.24 (3), p.719-727

2009

Volltextzugriff (PDF)

In Vitro Activity of 2,4-Diamino-6-[2-(Phosphonomethoxy)Ethoxy]-Pyrimidine against Multidrug-Resistant Hepatitis B Virus Mutants

Antimicrobial Agents and Chemotherapy, 2007-06, Vol.51 (6), p.2240-2243

2007

Volltextzugriff (PDF)

Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C

Journal of medical virology, 2007-08, Vol.79 (8), p.1075-1081

2007

Volltextzugriff (PDF)

1 – 25 von 537

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(482)
Mit Volltextzugriff
(484)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(249)
Science & Technology
(249)
Humans
(224)
Gastroenterology & Hepatology
(117)
Biological And Medical Sciences
(114)
Hepatitis B Virus
(114)
Infectious Diseases
(107)
Medical Sciences
(99)
Gastroenterology And Hepatology
(98)
Virology
(97)
Male
(94)
Antiviral Agents - Therapeutic Use
(93)
Life Sciences
(91)
Female
(85)
Hepatitis B Virus - Genetics
(82)
Adult
(80)
Middle Aged
(72)
Hepatitis B, Chronic - Drug Therapy
(68)
Viral Diseases
(62)
Human Viral Diseases
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antiviral therapies and prospects for a cure of chronic hepatitis B

Hepatitis B virus induced hepatocellular carcinoma

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells

New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus

New approaches to the management of hepatitis C in haemophilia in 2012

Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score

Mutations affecting the replication capacity of the hepatitis B virus

Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus

Implementation of an in-house quantitative real-time polymerase chain reaction method for Hepatitis B virus quantification in West African countries

Impact of Highly Active Antiretroviral Therapy (HAART) on the Natural History of Hepatitis B Virus (HBV) and HIV Coinfection: Relationship between Prolonged Efficacy of HAART and HBV Surface and Early Antigen Seroconversion

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT

Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients

Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co‐infected patients from Western Africa

Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis

Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemia

Implications of Unc5A depletion for hepatocyte survival in chronic liver diseases upon induction of the unfolded protein response

International coalition to eliminate hepatitis B - progress report

New HBV subgenotype D9, a novel D/C recombinant, identified in patients with chronic HBeAg-negative infection in Eastern India

Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy

Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

In Vitro Activity of 2,4-Diamino-6-[2-(Phosphonomethoxy)Ethoxy]-Pyrimidine against Multidrug-Resistant Hepatitis B Virus Mutants

Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C

Suchergebnisse filtern